121 related articles for article (PubMed ID: 30473216)
61. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
62. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
63. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.
Hua WF; Zhong Q; Xia TL; Chen Q; Zhang MY; Zhou AJ; Tu ZW; Qu C; Li MZ; Xia YF; Wang HY; Xie D; Claret FX; Song EW; Zeng MS
Cell Death Dis; 2016 Sep; 7(9):e2352. PubMed ID: 27584791
[TBL] [Abstract][Full Text] [Related]
64. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
65. Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Zlobec I; Terracciano LM; Lugli A
Clin Cancer Res; 2008 Jun; 14(12):3792-7. PubMed ID: 18559598
[TBL] [Abstract][Full Text] [Related]
66. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
67. Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.
Federico A; Zappavigna S; Romano M; Grieco P; Luce A; Marra M; Gravina AG; Stiuso P; D'Armiento FP; Vitale G; Tuccillo C; Novellino E; Loguercio C; Caraglia M
Eur J Clin Invest; 2014; 44(3):285-94. PubMed ID: 24372535
[TBL] [Abstract][Full Text] [Related]
68. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
69. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
70. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
71. LncRNA KLK8 modulates stem cell characteristics in colon cancer.
Wang K; Song W; Shen Y; Wang H; Fan Z
Pathol Res Pract; 2021 Aug; 224():153437. PubMed ID: 34271345
[TBL] [Abstract][Full Text] [Related]
72. Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.
Yue B; Cai D; Liu C; Fang C; Yan D
Mol Ther; 2016 Dec; 24(12):2064-2077. PubMed ID: 27633443
[TBL] [Abstract][Full Text] [Related]
73. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.
Yu Y; Nangia-Makker P; Farhana L; Majumdar APN
Mol Cancer; 2017 Sep; 16(1):155. PubMed ID: 28964256
[TBL] [Abstract][Full Text] [Related]
74. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
75. LncRNA‑NEF is involved the regulation of gastric carcinoma cell proliferation by targeting RUNX1.
Wang X; Jiang X; Zhou L; Wang Z; Huang H; Wang M
Mol Med Rep; 2019 Mar; 19(3):2051-2056. PubMed ID: 30664208
[TBL] [Abstract][Full Text] [Related]
76. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
77. LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression.
Yang Y; Zhang J; Chen X; Xu X; Cao G; Li H; Wu T
Gene Ther; 2018 Aug; 25(5):321-330. PubMed ID: 29925853
[TBL] [Abstract][Full Text] [Related]
78. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
79. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.
Wang SH; Zhang MD; Wu XC; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Sep; 37(9):12867-12875. PubMed ID: 27449039
[TBL] [Abstract][Full Text] [Related]
80. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
